New obesity treatment may help preserve muscle during weight loss
A new obesity treatment called retatrutide may help individuals lose weight while preserving muscle mass. Dr. Andrew Huberman discussed its benefits on a podcast, highlighting its triple-action mechanism compared to older weight-loss drugs. This treatment aims to reduce the side effects commonly associated with previous GLP-1 therapies.
- ▪Retatrutide is a triple agonist that activates receptors for GIP, GLP-1, and glucagon.
- ▪Unlike older medications, retatrutide may help preserve lean muscle during weight loss.
- ▪It is administered as a once-weekly subcutaneous injection in clinical trials.
Opening excerpt (first ~120 words) tap to expand
Health New obesity treatment may help preserve muscle during weight loss Andrew Huberman acknowledges retatrutide benefits but warns of gray-market suppliers By Khloe Quill Fox News Published May 20, 2026 5:17pm EDT Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google close Video Wellness Week: A closer look into peptide treatments Fox News correspondent Alexandria Hoff reports on the safety and legality of peptides, found in GLP-1 weight loss drugs, on ‘Special Report.’ NEWYou can now listen to Fox News articles! During a recent episode of her podcast, Gwyneth Paltrow spoke with neuroscientist Dr. Andrew Huberman about retatrutide, a new advancement in GLP-1 (glucagon-like peptide-1) therapies.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fox News — Latest.